Brief: Cytodyn Inc - Exploring Leronlimab As A Potential Treatment For Patients Infected With 2019 Novel Coronavirus
28/01/2020 13:17
Jan 28 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN INC - EXPLORING LERONLIMAB AS A POTENTIAL
TREATMENT FOR
PATIENTS INFECTED WITH 2019 NOVEL CORONAVIRUS
Source text for Eikon: ID:nGNX4jBCwk
Further company coverage: CYDY.PK
((Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer